Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Regulatory issues gene therapy

The use of nucleic acids as therapeutics is an unprecedented concept, and therefore the regulatory guidelines have evolved simultaneously with the technologies, and continue to do so. Because gene therapy using retroviral vectors is the most advanced of the nucleic acid therapies, regulatory issues and concepts are relatively better formulated in this area (Walters, 1991 FDA Report, 1991). [Pg.213]

Regulatory issues Severe (Gene therapy) Easy... [Pg.1005]

See other pages where Regulatory issues gene therapy is mentioned: [Pg.22]    [Pg.417]    [Pg.69]    [Pg.45]    [Pg.265]    [Pg.555]    [Pg.518]    [Pg.676]    [Pg.719]    [Pg.719]    [Pg.773]    [Pg.2]    [Pg.201]    [Pg.202]    [Pg.288]    [Pg.448]    [Pg.722]    [Pg.172]    [Pg.126]    [Pg.213]    [Pg.22]    [Pg.23]    [Pg.57]   
See also in sourсe #XX -- [ Pg.7 , Pg.11 , Pg.265 ]

See also in sourсe #XX -- [ Pg.288 ]



SEARCH



Gene therapy

Genes regulatory

© 2024 chempedia.info